CEA Antibody (RC67), mAb, Mouse

CEA (RC67), mAb, Mouse

Carcinoembroyonic antigen (CEA) is a glycoprotein, produced during the embryonic and fetal period. The high concentration of CEA in blood are observed in many patients with cancer of the lung, liver, pancreas, breast, colon and prostate. The elevated CEA levels are related to the stage of the disease.
V06202
¥21,497.00

Ask us a question
Overview
Specificity Human CEA
Recommended Pairs Sandwich immunoassay (Capture-Detection):
RC66–RC67
Clone ID RC67
Isotype IgG1 for mAbs RC67
Subclass IgG1
Host Species Mouse
Antigen Species Human

Properties
Conjugation Unconjugated
Production Cultured in vitro under conditions free from animal-derived components
Purification Protein A/G affinity column
Concentration ≥ 2mg/ml
Formulation 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% ProClin 300.
Storage For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.
Product Stability
Temperature, Time Results for clones
RC66 RC67
-80°C, 21 days OK
-20°C, 21 days OK
4°C, 21 days OK
20°C, 21 days OK
37°C, 21 days OK
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

Applications
Platform Capture Detection
ELISA RC66 RC67

Background
Target Background Carcinoembroyonic antigen (CEA) is a glycoprotein, produced during the embryonic and fetal period. The high concentration of CEA in blood are observed in many patients with cancer of the lung, liver, pancreas, breast, colon and prostate. The elevated CEA levels are related to the stage of the disease.
Synonyms CEA Antibody (RC67), mAb, Mouse

Limited Use License and Use Restrictions
Limited Use License and Use Restrictions This Product is provided under a limited, non-exclusive, non-transferable, and non-sublicensable end-user license strictly limited to the permitted uses set forth in GenScript’s official documentation, quotations, or written agreements. Any use beyond such scope requires GenScript’s prior written authorization or license.
Except as expressly authorized in writing by GenScript, Customer shall not, and shall not permit, procure, enable, or assist any third party to: (a) commercialize or otherwise exploit the Product, including by reselling, distributing, transferring, sublicensing, or otherwise making the Product (including any product incorporating the Product) available to any third party; (b) copy, reproduce, clone, reverse clone, sequence, analyze, characterize, deconstruct, reconstruct, reverse engineer, or otherwise attempt to discover the composition, sequence, structure, binding characteristics, epitope recognition characteristics, or other proprietary features of the Product; (c) modify, derivatize, humanize, optimize, mutate, design around, or generate any variants, derivatives, fragments, substitutes, or functional equivalents of the Product; or (d) use the Product, any information derived therefrom, or any computational, AI-enabled, or sequence-based design method to develop, manufacture, offer for sale, sell, or commercialize any product or service competitive with the Product or GenScript’s products or services.
All intellectual property rights and all rights not expressly granted herein are reserved by GenScript. No rights are granted by implication, estoppel, or otherwise.

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.